ID: ALA3770165

Max Phase: Preclinical

Molecular Formula: C33H44ClN7O4S

Molecular Weight: 670.28

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cc1cc(C[C@@H](NC(=O)N2CCN(c3ccc(S(C)(=O)=O)cc3Cl)CC2)C(=O)N2CCC(N3CCCCC3)CC2)cc2cn[nH]c12

Standard InChI:  InChI=1S/C33H44ClN7O4S/c1-23-18-24(19-25-22-35-37-31(23)25)20-29(32(42)40-12-8-26(9-13-40)38-10-4-3-5-11-38)36-33(43)41-16-14-39(15-17-41)30-7-6-27(21-28(30)34)46(2,44)45/h6-7,18-19,21-22,26,29H,3-5,8-17,20H2,1-2H3,(H,35,37)(H,36,43)/t29-/m1/s1

Standard InChI Key:  HPLDMLVYRDSJID-GDLZYMKVSA-N

Associated Targets(Human)

Calcitonin gene-related peptide 1 214 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 670.28Molecular Weight (Monoisotopic): 669.2864AlogP: 3.85#Rotatable Bonds: 7
Polar Surface Area: 121.95Molecular Species: BASEHBA: 7HBD: 2
#RO5 Violations: 1HBA (Lipinski): 11HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: 12.40CX Basic pKa: 9.62CX LogP: 2.55CX LogD: 0.34
Aromatic Rings: 3Heavy Atoms: 46QED Weighted: 0.39Np Likeness Score: -1.62

References

1. Civiello RL, Han X, Beno BR, Chaturvedula PV, Herbst JJ, Xu C, Conway CM, Macor JE, Dubowchik GM..  (2016)  Synthesis and SAR of calcitonin gene-related peptide (CGRP) antagonists containing substituted aryl-piperazines and piperidines.,  26  (4): [PMID:26832218] [10.1016/j.bmcl.2016.01.026]

Source